Tagoe Naa Naamuah, Essuman Vera Adobea, Bankah Patrick, Dakurah Thomas, Hewlett Vincent Kwaku, Akpalu Josephine, Ndanu Thomas Akuetteh
Eye Department, Korle-Bu Teaching Hospital, Accra, Ghana.
Ophthalmology Unit, Department of Surgery, School of Medicine and Dentistry, College of Health Sciences, University of Ghana, Accra, Ghana.
Ethiop J Health Sci. 2019 Jan;29(1):895-902. doi: 10.4314/ejhs.v29i1.11.
Craniotomy and transphenoidal microsurgery are surgical options for treatment of pituitary adenoma at Korle Bu Teaching Hospital(KBTH). Despite major advances and reported success rates of transphenoidal resection globally, paucity of local data regarding visual outcome of either procedure exists. We evaluated the visual outcome of patient with pituitary adenoma following surgery in a tertiary hospital in Ghana.
This is a prospective study of 18 of 45 consecutive new patients with pituitary adenoma seen from November 2010 to July 2013 at Korle-Bu Teaching Hospital(KBTH), Accra, Ghana. Sixteen (88.9%) of the 18 had surgery by transphenoidal route and 2(11.1%) by craniotomy. All patients had macroadenoma (tumour size >1cm) and histological confirmation of diagnosis. Pre-operative and post-operative visual acuity and its relationship to tumour size and duration of symptoms before diagnosis were evaluated.
Data on 18 patients aged 33-60 years, mean (SD) 45.9±8.5, was analysed. Eleven (61.1%) were females. Visual blur, 15(83.3%), and headache,13(72.2%), were predominant presenting complaints. Common neuro-ophthalmic signs included unilateral or bilateral optic atrophy, 17(94.4%), Relative Afferent Pupillary Defect (RAPD) in 8(44.4%) and impaired colour vision in 32 of 36(88.9%) eyes. Preoperatively, 8(22.2%) and 13(36.1%) of 36 eyes were visually impaired or blind respectively. Postoperatively, 6(16.7%) eyes were visually impaired and 17(47.2%) eyes blind. Blindness was associated with late presentation (p<0.005) and larger tumour width (p<0.036).
More than a third of eyes of patients with pituitary adenoma were blind before and after surgery. Blindness was associated with late presentation and larger tumours. Transphenoidal surgery may be beneficial following early diagnosis to avoid irreversible blindness/visual impairment.
开颅手术和经蝶窦显微手术是科勒布教学医院(KBTH)治疗垂体腺瘤的手术选择。尽管全球经蝶窦切除术取得了重大进展且报道了成功率,但关于这两种手术视觉结果的本地数据却很匮乏。我们评估了加纳一家三级医院中垂体腺瘤患者术后的视觉结果。
这是一项对2010年11月至2013年7月在加纳阿克拉科勒布教学医院(KBTH)连续收治的45例垂体腺瘤新患者中的18例进行的前瞻性研究。18例患者中有16例(88.9%)通过经蝶窦途径进行手术,2例(11.1%)通过开颅手术。所有患者均患有大腺瘤(肿瘤大小>1cm)且经组织学确诊。评估了术前和术后的视力及其与肿瘤大小和诊断前症状持续时间的关系。
分析了18例年龄在33 - 60岁之间、平均(标准差)为45.9±8.5岁患者的数据。其中11例(61.1%)为女性。主要症状表现为视力模糊,共15例(83.3%),头痛13例(72.2%)。常见的神经眼科体征包括单侧或双侧视神经萎缩,共17例(94.4%),8例(44.4%)有相对传入性瞳孔障碍(RAPD),36只眼中有32只眼(88.9%)存在色觉受损。术前,36只眼中分别有8只眼(22.2%)视力受损和13只眼(36.1%)失明。术后,6只眼(16.7%)视力受损,17只眼(47.2%)失明。失明与就诊延迟(p<0.005)和肿瘤宽度较大(p<0.036)有关。
垂体腺瘤患者超过三分之一的眼睛在手术前后失明。失明与就诊延迟和肿瘤较大有关。早期诊断后行经蝶窦手术可能有助于避免不可逆的失明/视力损害。